# The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot Study

> **NCT05723406** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Innate Inflammatory Response
- Osteoarthritis, Hip

## Interventions

- **DRUG:** Sugammadex 100 MG/ML [Bridion]
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05723406
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-21
- **Primary completion:** 2023-11-23
- **Final completion:** 2023-11-23
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05723406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05723406, "The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05723406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*